Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Proton Therapy × Thoracic × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 4 Gastrointestinal 3 CNS 2 Tumor-Agnostic 1 Thoracic 1 Sarcoma 1 Other solid neoplasm 1 Lymphoid 1

Conditions

Mesothelioma, Malignant 1

Interventions

Carboplatin 96 pembrolizumab 81 Pemetrexed 64 Cisplatin 55 Specimen Handling 42 Paclitaxel 39 durvalumab 33 Magnetic Resonance Spectroscopy 33 atezolizumab 32 Nivolumab 32 osimertinib 28 Docetaxel 26 Etoposide 20 Gemcitabine 19 Taxes 14 Radiotherapy 14 Radiosurgery 14 Ipilimumab 14 Drug Therapy 14 130-nm albumin-bound paclitaxel 14 cemiplimab 12 amivantamab 12 Platinum 11 Immunoglobulin G 11 Disulfides 11 Cetuximab 11 1,2-diaminocyclohexaneplatinum II citrate 11 Biopsy 10 tislelizumab 9 Bevacizumab 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05655078 2026-03-30

HIT-Meso

University College, London

Phase NA Recruiting

Other solid neoplasmThoracic

Mesothelioma, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡